Navigation Links
Pharmacopeia Announces Management Team Changes
Date:2/28/2008

ee years and, along the way, have assembled a solid group of scientists in both discovery and development as evidenced by today's announcements regarding Rene and David."

Dr. Belder has served as Vice President, Clinical and Regulatory Affairs since November 2006. He joined Pharmacopeia from Bristol-Myers Squibb, where during his 19-year tenure he served as a therapeutic expert in the areas of cardiovascular and metabolic diseases, and gained extensive global experience in leading clinical development programs and working with thought leaders in various clinical areas. His work included all phases of clinical development, as well as extensive interaction with the Food and Drug Administration, including leadership of the team responsible for the NDA for muraglitazar, a dual PPAR agonist.

Dr. Kimball has served as Senior Vice President, Chemistry and Preclinical Chemical Development since September 2007. Previously, he served as Vice President, Medicinal Chemistry at Lexicon Pharmaceuticals, where he successfully directed that company's chemistry effort to discover drug candidates in multiple therapeutic areas, several of which have entered clinical development. Prior to that, Dr. Kimball spent nearly 20 years at Bristol-Myers Squibb Pharmaceutical Research Institute. In various research roles at BMS, he oversaw innovative drug discovery and development projects in the areas of cardiovascular disease and oncology.

"Since joining Pharmacopeia, Rene and David have both made significant contributions to the success of the company's R&D," said Dr. Browne. "Both of these promotions are well-deserved and Pharmacopeia is fortunate to have these talented individuals playing critical roles in charting the scientific course for the company."

ABOUT PHARMACOPEIA

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference
2. Pharmacopeia to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Reminder Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
4. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
5. West Pharmaceutical Services Announces Quarterly Dividend
6. Beijing 2008 Olympic Games Vegetable Supplier Considering Kiwa as a Supplier of Bio-Fertilizers & Kiwa Announces CEO Interview with WallSt.net
7. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
8. Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance
9. DARA BioSciences, Inc. Announces Appointment of New Director to Board
10. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
11. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... 2014 Algenol Biofuels will present at CleanEquity Monaco ... of Monaco . Logo - ... annual invitation-only event hosted by Innovator Capital, the ... partners and sponsors include Prince Albert II of ... University, PR Newswire, the Monte-Carlo SBM, Oceanographic Museum of ...
(Date:11/15/2014)... Calif. , Nov. 14, 2014  F. ... by Continental Who,s Who as a Pinnacle Professional in ... role as President of Cell Point, LLC. ... offices in Centennial, Colorado , ... . The company,s five technology platforms, ethylenedicysteine drug ...
(Date:11/12/2014)... -- ReachBio Research Labs (a registered trade name of ReachBio ... that it has signed an agreement with Funakoshi Co., ... non-exclusive distribution rights to ReachBio,s human primary cell product ... Japan . Under a companion agreement, Funakoshi ... Japanese drug development companies. Photo - ...
(Date:11/12/2014)... (PRWEB) November 11, 2014 ... and one year of achieving GMP compliance with ... clearly defined and impressive blueprint for creating high ... and Requisition process and ending with the final ... where each product is in the process,” explains ...
Breaking Biology Technology:Algenol Biofuels Selected to Present at CleanEquity Monaco 2015 2F. David Rollo, MD, Ph.D., FACC, FACNP is recognized by Continental Who's Who as a Pinnacle Professional 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 3Innovative Formulations Achieves GMP Compliance and Success with InstantGMP™ MES 2
... 20 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading,pharmaceutical ... that,the company was named as a Top 100 ... by China Council for International,Investment Promotion (CCIIP) and ... This ranking covers outsourcing services in IT,pharmaceutical, ...
... ... 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies. ... Charlottesville, VA, San Diego, ... provider of technology and information solutions for the life sciences industry announced today a continuing ...
... , , , SAN ... VIAP ), a biotechnology company focused on the development of ... announced that it received a Staff Determination letter, dated July ... Company has not regained compliance with the minimum $2,500,000 stockholders, ...
Cached Biology Technology:OpenQ Posts a 200% Revenue Growth in the First Half of 2009 2VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ 2VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ 3VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ 4
(Date:11/5/2014)... has dedicated his career to understanding the Earth,s ... audience. , As deputy director and regional climatologist ... Desert Research Institute, Redmond has more than three ... dissemination of climate data to the general public. ... San Francisco on December 15-19, 2014 the American ...
(Date:11/4/2014)... School of Medicine announced today that it is ... by the Bill & Melinda Gates Foundation. ... and Reproductive Sciences; and Vice Chair of Research ... Medicine will pursue an innovative global health and ... Assess Fetal Neurodevelopment.", Grand Challenges Explorations (GCE) funds ...
(Date:11/4/2014)... – (Nov. 4, 2014) – A majority of Madagascar,s ... that could have serious consequences for the rainforests they ... shows the positive impacts lemurs can have on rainforest ... their disappearance could have on the region,s rich biodiversity. ... have fruits eaten by lemurs. Lemurs in turn ...
Breaking Biology News(10 mins):Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2Temple University School of Medicine receives Grand Challenges Explorations grant 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3
... Thirteen UC Riverside researchers have been named fellows of ... Including this years fellows, the total number of UCR ... distinction is 172., Election as a fellow is an ... year AAAS gave this honor to 486 of its ...
... strength along the California coast may have far-reaching effects, ... coast early in the season and increased fire danger ... Change and Impacts Laboratory at the University of California, ... present the findings in a poster titled "Future Changes ...
... The initial results of the first computer model ... representation of individual clouds have been analyzed by ... Research Center (IPRC) at the University of Hawai`i ... Technology (JAMSTEC), and the University of Tokyo. ...
Cached Biology News:13 UCR faculty members recognized by American Association for the Advancement of Science 213 UCR faculty members recognized by American Association for the Advancement of Science 3Stronger coastal winds due to climate change may have far-reaching effects 2
... 10X PCR Enhancer (with betaine) substantially ... sensitivity and specificity for amplification of ... Enhancer in PCR eliminates the base-pair ... enzyme?s thermal stability, suppresses pauses of ...
... provide rapid, precise localization of cell ... or paraffin-embedded tissue, cytospins and touch ... double or triple labeleing experiments, as ... primary antibodies of different animal species. ...
... HistoMark Biotin Streptavidin-HRP Systems provide rapid, ... intracellular antigens in frozen or paraffin-embedded ... These systems also facilitate double or ... be performed simultaneously with primary antibodies ...
... covers can be used with ... covers for stacking of covered ... for use with automated systems ... and non-ridged, are available for ...
Biology Products: